checkAd

    Traumchart und super Einstiegsmöglichkeit - 500 Beiträge pro Seite

    eröffnet am 23.09.05 12:09:15 von
    neuester Beitrag 23.09.05 12:20:21 von
    Beiträge: 6
    ID: 1.009.294
    Aufrufe heute: 0
    Gesamt: 1.157
    Aktive User: 0

    ISIN: US70336N1072 · WKN: 899459
    0,0051
     
    USD
    -10,53 %
    -0,0006 USD
    Letzter Kurs 02.12.20 Nasdaq OTC

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 23.09.05 12:09:15
      Beitrag Nr. 1 ()
      Patriot Scientific Corp, WKN: 899459

      Kurs wird in den USA gemacht

      Die 200 Tages Linie wurde vorgestern getestet, um dann gestern wieder oberhalb zu schließen.

      Sehe hier für mittel- bis langfristige Anleger große Potentiale, wobei auch zwischenzeitliche Kurssprünge möglich sind ;)

      Avatar
      schrieb am 23.09.05 12:14:02
      Beitrag Nr. 2 ()
      Patriot Scientific Files 2005 Form 10-K, Representing Important Milestone in Company Turnaround Under New Management
      Wednesday September 14, 11:59 am ET

      SAN DIEGO--(BUSINESS WIRE)--Sept. 14, 2005--Patriot Scientific Corporation (OTCBB:PTSC - News) a high-tech intellectual properties company working in the advanced microprocessor field, today filed its 10-K annual report for its fiscal year ending May 31, 2005. The report, filed with the U.S. Securities and Exchange Commission, includes audited financial statements for its fiscal year and related disclosures concerning the company`s results of operations and financial condition during that period.

      "This filing is an important milestone for Patriot Scientific," said David H. Pohl, chairman and CEO. "While the 10-K presents mostly historic data, it provides the clearest picture yet of the challenges that the company faced and the exciting position we are now in to transform the way Patriot conducts its business. We now have an excellent basis for moving forward with financial momentum."

      Activities at Patriot Scientific that have occurred since the close of the fiscal year covered in the 10-K include:

      * Appointment of new executive management focused on Patriot`s new business opportunities
      * Favorable settlement of major litigation that was a drain on resources.
      * A license with Intel Corporation for rights to use Patriot Scientific intellectual property
      * A commercialization agreement delegating authority for licensing activities for the Patriot Scientific intellectual property portfolio to an aggressive, experienced team of licensing professionals
      * Licensing revenue that places the Company on a firm financial footing
      * Continuation of rights to develop and market intellectual property products including IGNITE(TM) and INFLAME(TM)

      A copy of the Company`s 10-K is available for download at www.patriotscientific.com

      About Patriot Scientific

      Patriot Scientific (OTC Bulletin Board: PTSC.OB - News) has emerged as an effective and dynamic intellectual property company, developing and marketing innovative and proprietary semiconductor technologies into the fast-growing handheld wireless and smart card markets. The company`s portfolio of proprietary designs encompasses what is believed to be fundamental ultra-low-power array microprocessor technology, as well as pending patents designed to protect Patriot`s proprietary technology and architecture.

      Detailed information about Patriot Scientific can be found on the website www.ptsc.com. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found on the websites www.hawkassociates.com and www.hawkmicrocaps.com.

      Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company`s cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company`s Securities and Exchange Commission filings.
      Avatar
      schrieb am 23.09.05 12:15:32
      Beitrag Nr. 3 ()
      The `336 Patent is listed in the Patent and Trademark Office (PTO) along with several other Patriot Scientific patents, as having been co-invented by Russell H. Fish, III, and Charles H. Moore. Some years ago, Fish`s interests in these patents were transferred to the Fish Family Trust, then to Nanotronics Corporation, then to Patriot.

      In December 2003 the company filed lawsuits in several U.S. district courts against companies - Sony Corporation of America, Fujitsu, Toshiba America, Inc., NEC USA, Inc., and Matsushita - that it believes are infringing the `336 entitled " High Performance Microprocessor Having Variable Speed Clock." Patriot Scientific has asked the courts to enjoin the defendants from making use of the PTSC patent and are requesting damages for past infringements. In February, with the consent of the defendants, the above five actions were consolidated into the Fujitsu action.

      In February 2005, Patriot Scientific reached an agreement with AMD (NYSE: AMD) in which AMD purchased restricted shares from PTSC, obtained rights to manufacturer and sell the PTSC IGNITE 32-bit stack microprocessor and obtained rights to Patriot’s `ShBoom` microprocessor patent portfolio in its entirety. AMD was the first company to license the `ShBoom` microprocessor portfolio from PTSC. Terms of the agreements were not disclosed.

      In June 2005, PTSC and The TPL Group agreed to unify their interests in key microprocessor patents. Under the terms of this agreement, the firms agreed to form a joint venture with equity ownership split evenly among both companies. The joint venture will grant TPL Group full responsibility and authority for the commercialization and licensing of the unified patents portfolio.

      The joint accord ended years of litigation between Patriot Scientific and The TPL Group over title to the patents. Through the new joint venture, Patriot Scientific and TPL will share equally in the revenues generated by the licensing program implemented by TPL. The costs of standing up the joint venture will be split evenly among the two companies.

      TPL and Patriot believe at least three of the 10 patents are elemental to virtually every microprocessor design. The three most significant of these patents are as follows:


      U.S. 5,809,336: Clocking CPU and I/O Separately
      U.S. 6,598,148: Use of Multiple Cores and Embedded Memory
      U.S. 5,784,584: Multiple Instruction Fetch
      Both The TPL Group and Patriot Scientific believe these unified patents, which were granted in 1998 and which don’t expire until 2015, have long been essential to the design of modern high-speed microprocessors. These two firms are now in position to maximize the value of this patent portfolio. Global sales by potential licensees of products applying technologies protected by the jointly owned patents are estimated to be greater than $200 billion annually.
      Avatar
      schrieb am 23.09.05 12:16:35
      Beitrag Nr. 4 ()
      :rolleyes:Hier ist der Boden noch lange nicht erreicht! Würde auf diesem Niveau vorsichtig sein und nicht einsteigen!:(
      Avatar
      schrieb am 23.09.05 12:19:24
      Beitrag Nr. 5 ()
      Im Patriot Thread Thread: 2 Milliarden Dollar: Patriot Scientific klagt gegen Intel findet ihr alle wichtigen infos.

      Sehe hier mehr Chancen als Risiken und der aktuelle Kurs, unter Berücksichtigung des Charts, schreit förmlich kauf mich.

      Nichts desto trotz gibt es auch Risiken, also handelt weise ;)

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1975EUR +5,90 %
      InnoCans LPT-Therapie als Opioid-Alternative?! mehr zur Aktie »
      Avatar
      schrieb am 23.09.05 12:20:21
      Beitrag Nr. 6 ()
      @tombow

      was sind die gründe für deine annahme?


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      Traumchart und super Einstiegsmöglichkeit